Questions About Drug Safety System Emerge After Arthritis Drug ...
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
392614
Amidst recent prescription drug recalls, health experts have tips for patients to determine the safety of their medications. Merck Pharmaceuticals&#39; September decision to withdraw its widely used arthritis
415864
Arthritis patients who use pain-relief medications similar to Vioxx may have cause for concern. Merck, the maker of Vioxx, pulled it from the market when it said research had found it doubled the risk of heart problems.
754465
By E.J. Mundell, HealthDay Reporter    Other drugs on the market offer arthritis relief, experts say    HealthDayNews -- A day after one of the largest drug recalls in history, America's 2 million Vioxx users are left wondering what's next in terms of relieving their arthritis pain...
715716
NEW YORK  - Patients with rheumatoid arthritis who fail to respond to one of the biological drugs will often have a better response to a second drug within the same class, Danish researchers report in the Annals of the Rheumatic Diseases.
488549
WASHINGTON -- A veteran Food and Drug Administration safety officer yesterday told a Senate hearing inquiring into the abrupt recall of the arthritis drug Vioxx that five other widely used drugs should be either withdrawn or sharply restricted because they have dangerous side effects.
142093
The good news about the latest blockbuster-drug debacle, this one involving the arthritis medication Celebrex, is that the consumer-protection system -- such as it is -- appears to have worked.
521954
NEW YORK (CBS) The recent recall of the arthritis drug Vioxx has a lot of patients worried about the contents of their medicine cabinets and wondering what the alternatives might be.
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
2126
Shares of large US and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of US regulators in monitoring drug safety.
612661
U.S. drug safety regulators are coming under fire for their response to years of suspicions, confirmed last week, that arthritis drug Vioxx increased the risks of heart attacks and strokes.
161619
The fight over the lucrative market for rheumatoid arthritis drugs is heating up. In the last five years, three similar drugs have been introduced that offer patients the promise of getting back on their feet. Now the manufacturers of all three are jockeying for market share so they can be the leader when Medicare's full prescription drug benefit takes effect ...
277613
[India News]: New York, Dec 20 : America&#39;s multibillion dollar pharmaceutical industry has been shaken by reports that Pfizer&#39;s high-profile arthritis drug, Celebrex, is said to cause an increased risk of heart attack.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
462742
People who use the drug Remicade for rheumatoid arthritis may be at increased risk of a serious blood disorder, the US Food and Drug Administration warned.
90441
The drug maker says a three-year study of the arthritis pain medication demonstrated a higher risk of heart attack and stroke in patients using the drug.